Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-21-051214

Chief Medical Officer sold 10,000 shares at $100.00 ($1,000,000)

  • Chief Medical Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Detke Michael J. · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-10 Exercise or conversion : show line 1 in the form +10,000 $2.23 $22,300 10,000 D
2021-08-10 Sale : show line 2 in the form −10,000 $100.00 $1,000,000 0 D
Open-market sales · 10,000 sh · avg $100.00 · $1,000,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-10 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −10,000 92,352 D
Loading xslF345X03/doc4.xml…